Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
Reginster
J Y
JY
Bone Metabolism Unit, University of Liège, Belgium.
Gennari
C
C
Mautalen
C
C
Deroisy
R
R
Denis
D
D
Lecart
M P
MP
Vandalem
J L
JL
Collette
J
J
Franchimont
P
P
D000281:Administration, Intranasal; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D000906:Antibodies / Q000032:analysis / Q000502:physiology*; D000918:Antibody Specificity; D002116:Calcitonin / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D003401:Creatine / Q000652:urine; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000097:blood / Q000628:therapy* / Q000652:urine
D000906:Antibodies; D007074:Immunoglobulin G; C028815:salmon calcitonin; D002116:Calcitonin; D000469:Alkaline Phosphatase; D003401:Creatine; D006909:Hydroxyproline